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Once viewed simply as a reservoir for carbon storage, lipids are no longer cast as bystanders in the
drama of biological systems. The emerging field of lipidomics is driven by technology, most notably
mass spectrometry, but also by complementary approaches for the detection and characterization
of lipids and their biosynthetic enzymes in living cells. The development of these integrated tools
promises to greatly advance our understanding of the diverse biological roles of lipids.Lipids are not genetically encoded. Instead, like other small
molecules they are generated and metabolized by enzymes
that are influenced by the environment of a given biological
system, for instance by diet and temperature. Although still
poorly defined, some estimates have placed the number of
distinct chemical entities within the lipid sphere between
10,000 and 100,000. Although it is unclear how and why nature
generates this staggering diversity, there is an increasing aware-
ness across many disciplines of the critical importance of lipids
in all aspects of life.
First, coordinated lipid anabolism and catabolism is a key
molecular integrator of energy homeostasis, membrane struc-
ture and dynamics, and signaling (Figure 1) with imbalances in
lipid metabolism contributing to diverse phenotypes and disease
states. Second, there is an expanding number of drugs that
target lipid metabolic and signaling pathways, including the
well-known and profitable cholesterol-lowering agents (statins)
and cyclooxygenase inhibitors. For therapeutic intervention in
diseases ranging from inflammation and cancer to metabolic
diseases, lipid researchers are seeking specific regulators of
numerous targets, including phosphatidylinositol (PI) 3-kinases,
nuclear hormone receptors (for instance, liver X receptor, LXR;
peroxisome proliferator-activated receptors, PPARs), sphingo-
sine, and ceramide kinases. A recent example is FTY720,
approved for the treatment of multiple sclerosis in October
2010, an immunosuppressant that targets sphingosine-1-phos-
phate receptors (but interestingly does not inhibit serine palmi-
toyl transferase, unlike its mother compound myriocin, a natural
product).
The scarcity of pertinent tools has led to investments in
programs to develop new approaches for lipid research. Collec-
tively, these efforts have added momentum to the field (reflected
in part by the increasing number of publications and conferences
dedicated to lipids), which promises to address fundamental
questions of lipid function and to meet practical demands in
the applied sciences. The aim of this Primer is to introduce the
basic concepts behind biochemical (mass spectrometry-based)
lipidomics, to discuss how these approaches are being inte-
grated with complementary techniques, and to offer a view on
the future of the field.888 Cell 143, December 10, 2010 ª2010 Elsevier Inc.Mass Spectrometry-Based Lipidomics
The first reports of mass spectrometric (MS) analysis of complex
lipid mixtures via soft ionization techniques (matrix-assisted
laser desorption ionization, MALDI, and electrospray ionization,
ESI) date back to the 1990s (Han and Gross, 1994; Kim et al.,
1994). A large number of methods have been developed since
then, and many biologically important lipids can now be
analyzed on a fairly routine basis. However, unlike genomics
and proteomics, which are well represented in various forms at
leading research institutions worldwide, this is not yet the case
for lipidomics (Figure 2).
A major difference in mass spectrometry of lipids (as opposed
to proteins) is the large chemical diversity found in these
molecules (Figure 1 andFigure 3A) (Fahy et al., 2005). As a conse-
quence, it is currently not possible to comprehensively measure
the lipidome of a cell or tissue in a single experiment. Further-
more, one often does not know what precise alteration in lipids
to expect in any given case. Thus, first surveys are often
exploratory, which is to say they often have ‘‘untargeted’’ read-
outs (Figure 3B). Suchmethods should have highmass accuracy
and resolution, a characteristic of time of flight andOrbitrapmass
spectrometry. Fragmentation of an ion of interest is then used for
identification (Figure 3C). Analysis of fragmentation pathways
has led to a detailed understanding of ‘‘bonding’’ between the
different building blocks found in lipids (such as fatty acids,
sphingoid bases, and head groups). It has also formed a basis
for ‘‘shotgun’’ lipidomics inwhich precursor lipids are determined
based on characteristic fragment ions. Other targeted ap-
proachesbasedon tandemmassspectrometry arenowavailable
for analysis of many different classes of lipids and in complex
mixtures (Wenk, 2005; Blanksby and Mitchell, 2010).
The coordinated efforts of LIPIDMAPS (http://www.lipidmaps.
org) have laid the groundwork for standardization (for example, in
protocols and in the nomenclature relevant to databases) in the
field and to foster the commercial availability of many pure and
synthetic lipid standards. These standards are deuterated
versions or close chemical analogs of naturally occurring lipids
that are used to quantify ion responses. They are used in a rapidly
increasing number of lipidomic programs around the world
(LIPID MAPS, Kansas Lipidomics Research Center, COBRE,
Figure 1. The Cellular Compartments of Common Biological Lipids
Lipids are small molecules of enormous chemical diversity. Unlike other major biomolecules (i.e., nucleic acids, polysaccharides, and proteins), they are not
polymers of relatively small numbers of chemically distinct building blocks. Instead, they are the result of anabolic and catabolic reaction pathways that are under
complex dietary and physiological control. It is thus difficult to define, name, and categorize lipids in a coherent and comprehensive fashion. Lipids of different
chemical structures are highly organized within a typical eukaryotic cell. The lipid portion of biological membranes is to a large extent made up of glycerophos-
pholipids, sterols, and sphingolipids (blue box, structures of three representative lipids from the different classes are shown). These are all examples of
amphiphilic lipids, which have both hydrophilic and hydrophobic portions. The membrane-associated lipids are not evenly distributed. Some organelles are
enriched with certain lipids (for instance, cardiolipin in mitochondria and lysobisphosphatidic acid/bis(monoacylglycero)phosphate in endosomes), and lateral
distribution within membranes leads to functional domains. Metabolism of membrane lipids generates highly active signaling molecules (red box). These lipids,
often much more soluble and diffusible than their membrane-associated parent, control organismal physiology. Very nonpolar lipids, such as sterol-esters and
triglycerides, are assembled in the endoplasmic reticulum and stored in lipid bodies within cells.WUSTL, Southampton Lipidomics Research Group, Lipidomics.
Net, LipidX, Lipidomics Research Center Graz, LipidProfiles). In
addition to these centers that harbor substantial analytical
capabilities, individual laboratories are increasingly engaging in
the analysis of specificmetabolites and lipid pathways. The latter
development can be explained, at least in part, by lowered costs
and easier handling of modern mass spectrometers.
Two technical characteristics, high sensitivity and high
specificity (mass resolution), account for the success of mass
spectrometry in lipid analysis. For example, mass spectrometry
has provided adetailed knowledge of the chemical (lipid) compo-
sition of highly purified vesicles or viruses, preparations in which
sample amounts are limited. These ‘‘organelles’’ stay largely
intact during preparation andare thus biochemicallymore acces-
sible than other membrane fractions. Studies such as these
provide evidence for segregation of specific sterol and sphingo-
lipid species during formation of secretory vesicles at the trans-
Golgi (Klemm et al., 2009) or enrichment of certain membrane
lipids during formation of viruses at donor membranes of the
host cell (Bru¨gger et al., 2006; Chan et al., 2008). Sensitivity is
also required for lipid metabolites that occur at low and transient
levels. Phosphoinositides or fatty acyl derivatives have all beencharacterized by mass spectrometric methods and in complex
lipid extracts, a task that would otherwise require laborious
(and often indirect) techniques for detection. It should however
be noted that, even with the major advances made by MS
approaches, the detection of lipid species of very low abundance
is still a major challenge (discussed below).
High-resolution mass spectrometry aids in identification of
previously uncharacterized lipids and discrimination between
lipids with similar mass and chemical structures. It has also
provided evidence for the presence of isomeric species (which
have the same chemical formula but different structures) and
isobaric species (ions with the same mass) in cellular lipidomes.
For example, ether phospholipids are often isomeric with other
abundant cellular phospholipids (Yang et al., 2007).
There are several analytical challenges that cannot be
addressed satisfactorily by mass spectrometry alone. These
include unequivocal assignment of structures: double bond
configurations are difficult to determine and cannot be readily
assigned based on tandem mass spectrometry (Thomas et al.,
2009); chemical derivatization and/or nuclear magnetic reso-
nance might be required for structure determination of complex
glycolipids.Cell 143, December 10, 2010 ª2010 Elsevier Inc. 889
Figure 2. Lipidomics Is an Emerging Field
The sequencing of the human genome in the year 2000 sparked interest and
investment in technologies and programs for the systematic analysis of
genetic variation. As a result, the study of genomes and proteomes has
produced large numbers of findings reported in the scientific literature
(measured here as the cumulative numbers of citations in PubMed over
time). Complete genomes can now be sequenced (and annotated) in a matter
of days or weeks, and current development is primarily focused on lowering
the cost per sequenced base. Many commercial products are available for
sample preparation, analysis, and interpretation. This is also true for protein
analysis, though it is still challenging to determine whole proteomes. Proteo-
mics has gained tremendously from mass spectrometry for peptide detection
and quantification. The boundaries for experimental measurements (such as
number of proteins) are reasonably well established based on genetic informa-
tion. None of the above is the case for lipidomic analysis. Currently, most of the
mass spectrometric measurements are conducted by a few consortia and
laboratories. The community is growing very rapidly, however, and these
activities have led to interest in many disciplines. The first studies combining
genomics and lipidomics have just been published. Given the central role of
lipids as key metabolites with remarkably diverse biological roles, the field of
lipidomics may follow a trajectory comparable to the developments seen in
genomics and proteomics over the past decade.
Figure 3. New Research Tools for Lipidomics
The precise size and dynamics of a cellular lipidome remains poorly under-
stood both on theoretical as well as on experimental grounds. Hundreds to
thousands of different chemical entities are recovered in an organic extract
from a biological specimen where lipids are assembled in a coordinated
fashion.
(A) An assembly of fatty acyl-containing membrane lipids with different head
group decorations, for example phosphorylated (1) or glycosylated (2) forms,
is depicted. Lipases hydrolyze lipids at various positions. Phospholipases
A2 generate lysolipids (3), which have profound structural effects on lipid
assemblies as well as signaling functions via G protein-coupled receptors.
Less well understood are other modifications such as hydroxylations or
methylations and oxidations or nitrosylation introduced via enzymatic and
chemical reactions, respectively (4).
(B) Single stage and tandem mass spectrometry (C) have yielded tremendous
insight into chemical details of cellular lipids. An ion with a mass/charge (m/z)
ratio corresponding to the expected structure shown in red (structure 1 in
panel A) can be fragmented and characterized based on product ions, which
in the case of glycerophospholipids and negative mode ionization are fatty
acyls, head group, and backbone-derived moieties.
(D) Complementary technologies that are currently being developed include
chemical-biological approaches to probe lipid-protein interactions. For
example, lipid-binding domains are used to visualize lipids in living cells or
to locally interfere with lipid metabolism.
(E) Analogues of lipids can be introduced into cells to interfere with protein-lipid
interactions, to inhibit enzymes, or for biochemical isolation of lipid-binding
factors.
(F) Finally, bioinformatic tools will need to be further developed to support
these experimental technologies (panels B–E) to facilitate combinations of
genomics and lipidomics, compare between biological species, and identify
clinically relevant biomarkers.Current Challenges
Integration
Lipids and their metabolites serve as integrators of many cellular
functions. Energy homeostasis is tightly coupled to fatty acid
metabolism, and fatty acids are key building blocks of many
cellular lipids (Figure 1). Thus, it seems evident that lipid metab-
olism must follow a very coordinated program during the cell
cycle and proliferation. Given that cancer cells are dependent
on fatty acids for the synthesis of membranes and signaling
lipids, fatty acid synthase (FAS) is considered a potential thera-
peutic target. Recent work using cell biological approaches
(Kurat et al., 2009) and functional proteomics (Nomura et al.,
2010) discovered that breakdown of glycerolipids via lipases is
a key mechanism for the generation of free fatty acids during
cell proliferation, thus metabolically coupling lipid bodies with
membrane synthesis (Figure 1) (Singh et al., 2009). Similar
metabolic coupling, for instance, between membrane lipids
and soluble lipid mediators, is likely to be discovered for specific890 Cell 143, December 10, 2010 ª2010 Elsevier Inc.phenotypes other than growth (Patwardhan et al., 2010). The
known lipid ‘‘signaling’’ network is thus poised for a great
expansion, in particular in the context of human disease
(Wymann and Schneiter, 2008).
These are recent examples of integrated experimental
approaches involving experiments that combine lipid biochem-
istry (via mass spectrometry or other means) and functional
readouts. The first challenge in such endeavors is defining the
sample. Whole-cell extracts are often used, and as a conse-
quence all information on spatial distribution is lost (van Meer,
2005). In the future, ensembles of protein markers will allow for
better identification of subcellular organelles (Andreyev et al.,
2010) and thus aid in preparations of lipid fractions related to
specific cellular functions. The generation of lipid extracts prior
to analysis is a critical aspect that currently attracts only
moderate attention. Biochemical fractionation has inherent
limitations in terms of the resulting purity and integrity of the
samples. Furthermore, recovery rates during partitioning in
organic solvents strongly depend on the lipid class, and
nonquantitative recovery during extraction introduces variability.
Natural Variation
Metabolites can vary substantially between individuals and on
a day-to-day basis (Assfalg et al., 2008), which complicates
comparative studies. Often, the degree of natural variation of
a metabolite/lipid in an individual or population is not known. In
mice, some lysolipids display remarkable circadian patterns
with up to 2-fold differences in their levels (Minami et al., 2009).
Whereas modern mass spectrometers provide linear outputs
over several orders of magnitude (linear dynamic range), the
biologically relevant dynamic range is lipid specific, varying
from 2- to 3-fold for abundant membrane lipids to 10- to 100-
fold in extreme cases (such as mediator lipids). Importantly,
lipids are also found at very different basal concentrations and
have distinct temporal dependencies. Cellular fractionation,
liquid chromatographic separation prior to MS (LC-MS), time
course experiments, as well as selective capture of lipids will
be required to overcome analytical challenges to resolving lipid
species of interest when they are of low abundance. In cellular
studies, metabolic labeling with chemical isotopes of lipid
precursors followed by mass spectrometry is an elegant and
powerful way to study kinetics of incorporation and turnover of
some classes of lipids (Postle and Hunt, 2009).
In population studies, efforts to combine mass spectrometry-
based lipidomics with genomics have been guided by the
technical feasibility of measuring lipids on a large scale, the
popularity of genome-wide association studies (GWAS), and
human diseases associated with aberrant lipid metabolism.
Strong associations are found between the levels of some poly-
unsaturated fatty acids (measured as fatty acid methyl esters by
gas chromatography-MS) and lipid desaturases (Tanaka et al.,
2009). GWAS with larger numbers of metabolic traits, measured
via MS methods introduced above, have been conducted and
published recently. In one study following 33 metabolic traits,
several circulating sphingolipids were found to be under strong
genetic control (Hicks et al., 2009). In another study with 163
metabolites (including major glycerophospholipids as well as
acyl-CoAs and amino acids), ratios of substrate-product
concentrations, rather than single metabolite levels, reduced
variance and improved statistical significance (Illig et al., 2010).
Sequencing of candidate genes in individuals at the extremes
of the population distribution with respect to lipoprotein levels
led to the discovery of nonsynonymous sequence variants in
enzymes involved in cholesterol metabolism (Fahmi et al.,
2008). Targeted genomics of lipid metabolic pathways in
combination with biochemical lipid analysis is an area of great
future potential. The link between genetic variation and changesin lipid levels will be relevant not only for population-based
studies but also at the level of individuals.
Data Analysis and Interpretation
Arguably, proteomics was transformed by the development
of search algorithms that enabled assignment of protein
sequences by comparisons of experimental and theoretical MS
fragmentation patterns of tryptic peptides. In the case of lipids,
the bioinformatic needs are different and to a substantial extent
remain unmet. Biological lipids are small, nonpolymeric mole-
cules (with molecular weights less than 2000 Da). Typical analyt-
ical readouts in ‘‘untargeted’’ approaches include retention time
(in the case of LC separation), mass-to-charge ratio, (m/z, ideally
with high mass accuracy), and information on fragment ions (in
the case of tandem MS). ‘‘Targeted’’ analysis delivers a matrix
of lipid identities (including precursors to fragment ions) and their
intensities. Typical informatic frameworks include data process-
ing (peak integration, identification, and normalization), statistics
(univariate or multivariate), and integration into pathways (e.g.,
the Kyoto Encyclopedia of Genes and Genomes, KEGG) or other
datasets (see above). Open source and commercial software
packages are now becoming available to support some of these
functions (Wheelock et al., 2009; Blanksby and Mitchell, 2010).
Building databases for lipids follows closely related efforts for
other small molecule metabolites (Fahy et al., 2007; Kind et al.,
2009). Appropriate data processing and validation will be a
particularly critical element in biomarker discovery where many
hundreds of different lipids are measured in human body fluids
such as blood plasma (Quehenberger et al., 2010).
These examples illustrate the benefits of data integration at all
levels and across scientific disciplines. Biochemical analysis of
lipids by mass spectrometry is only one element in such interdis-
ciplinary projects but will be a key tool in many fields including
cell and developmental biology, molecular medicine, and
nutrition (Shevchenko and Simons, 2010).
Future Developments and Prospects
New features and functions will undoubtedly be introduced to
augment those currently used in the MS analysis of lipids. For
instance, ion mobility mass spectrometry (IM-MS), which com-
bines information of molecular shape (the collisional cross-
section) with the mass/charge, has not yet been extensively
applied to the analysis of lipids. Biophysical studies have shown
that the double bond configuration of fatty acyls determines the
conformation of lipids in bilayers, and this structural character-
istic might also affect the collisional cross-section. It is also
conceivable that ionmobility is affected by head group geometry
(which is impacted by phosphorylation and glycosylation). Thus,
it is likely that IM-MS will provide valuable information that is
otherwise difficult to obtain. IM-MS has been successfully
used for detection of lipids directly from tissue sections via
MALDI (Ridenour et al., 2010). The resulting ‘‘image’’ containing
mass spectral data yields spatial information on lipid distribution
(Murphy et al., 2009).
Many lipids bind to cations, such as Ca2+ and Mg2+, via their
charged head groups. These reactions regulate assembly of
lipids in biological as well as cell-free systems. Lipid oxidation
on the other hand is in part coupled to free radical chemistry.
Thus, elemental composition of lipid preparations (metal ions inCell 143, December 10, 2010 ª2010 Elsevier Inc. 891
particular) could yield important additional information related to
biomarker discovery. Such information can be determined by
inductively coupled plasma (ICP) mass spectrometry (Becker
and Jakubowski, 2009), a method that is amenable to imaging.
An interesting new technique for imaging of lipids is coherent
anti-stokes Raman scattering (CARS) microscopy. Images are
generated based on the vibrational states of molecules, such
as the CH2 bonds found in fatty acyls. Thus, CARS does not
require external labels. It is rapid (1 s/frame) and can be used
for live imaging. Currently, CARS works well in applications
with high signal-to-noise ratios, for example lipid bodies that
harbor many CH2 segments (Volkmer, 2005; Mu¨ller and Zum-
busch, 2007). Future developments might lead to CARS
spectroscopy, moving the technique beyond the monitoring of
a single frequency such that C-C double bonds (lipid unsatura-
tion), or ester bonds could also be imaged. Such refinements
should also help overcome background problems.
Molecular Recognition of Lipids
Substrate Specificities
Progress has been made toward ascertaining the determinants
of specificity for lipid enzymes and protein effectors. For
instance, mammalian FAS generates mainly palmitic acid
(C16:0,16 carbons and no double bonds between them) and to
a lesser extent produces C14:0 and C18:0. This specificity is
determined, at least in part, by the thioesterase domain of FAS
and the geometry of its catalytic cavity (Pemble et al., 2007).
Phospholipases and lipid kinases are other well-studied exam-
ples. Both require interfacial targeting and specific recognition
of their substrates for catalysis (Manford et al., 2010). Phosphoi-
nositides, an important class of cellular signaling lipids, are
recognized by a large number of protein effectors that have
vastly different folds. Sophisticated technology based on induc-
ible formation of protein-protein complexes (Suh et al., 2006) or
peptide sensors has helped to monitor (using optical imaging)
the distributions of phosphoinositides and associated protein
factors within cells (Fairn et al., 2009).
Despite these advances, it is clear that recognition of lipids at
the atomic level remains poorly understood (Manford et al.,
2010; Ernst et al., 2010). It is becoming increasingly evident
that highly specific lipid-lipid and lipid-protein interactions
regulate cell physiology (Guan et al., 2009; Shevchenko and
Simons, 2010). It will therefore be a challenge to understand
and therapeutically target such interactions. Lipid enzymes are
an interesting case to consider given that they produce media-
tors that have closely related structures but opposing functions
(Figure 1). Cyclooxygenase 2 (COX-2) is involved in the genera-
tion of both inflammatory compounds (e.g., prostaglandins) as
well as anti-inflammatory compounds from similar, albeit chem-
ically distinct, substrates (glycerophospholipids with omega-6
and omega-3 fatty acyl, respectively) (Groeger et al., 2010).
Acetyl-salicylic acid (aspirin), a natural compound that targets
COX-2, decreases production of proinflammatory mediators
and increases production of anti-inflammatory compounds.
This shift in COX activity is not achieved by synthetic and selec-
tive inhibitors of COX that are designed based on active site
catalysis. Chemically synthesized derivatives of natural products
are therefore promising tools for probing enzyme cavities and892 Cell 143, December 10, 2010 ª2010 Elsevier Inc.for identifying new lipid-binding factors and off-targets (Yang
et al., 2010).
Enzymatic versus Chemical Modification of Lipids
Unlike the generation of ‘‘lipid mediators’’ (Serhan, 2009), oxida-
tion of intact glycerophospholipids can be mediated by reactive
oxygen species in addition to enzymes such as lipoxygenases.
Typically, oxidation of polyunsaturated fatty acyls (PUFAs) in
glycerophospholipids by reactive oxygen species leads to a
variety of different products including hydroxyls, hemiacetals,
and furans. Oxidized forms of membrane phospholipids are
short-lived, reactive species that undergo fatty acyl chain short-
ening or covalent adduct formation with nearby proteins.
Furthermore, such ‘‘damaged’’ lipids occur in very low abun-
dance compared to their parent lipid thus complicating analytical
capture (Zemski Berry et al., 2010). These lipids might exert their
effects via receptor activation (for instance via G protein-coupled
receptors, nuclear receptors, and/or innate immune receptors;
Greenberg et al., 2006) and other mechanisms due to their reac-
tivity and biophysical properties (Deigner and Hermetter, 2008).
The proportion of fatty acyls differs dramatically between
organs. The brain, for example, is very rich in polyunsaturated
fatty acyls (such as arachidonic acid, C20:4, and docosahexae-
noic acid, C22:6), whereas the liver contains primarily saturated
and monounsaturated fatty acyls. It is thus conceivable that
oxidative stress might produce different lipid reaction products
depending on the precise organ and/or cell type affected. This
would influence downstream reactions such as activation of
cell surface or nuclear lipid receptors and elevation of antibodies
directed against lipids (discussed below). This characteristic is
also relevant for biomarker development, which would require
careful inspection and understanding of chemical versus enzy-
matic oxidations as well as an appreciation of the potential for
selective transport as in the case of oxidized sterols.
Antibodies Directed against Lipids
With the important exception of glycolipids, relatively few
antibodies that recognize specific lipids have been described.
This cannot be ascribed solely to an inherent lack of antigenicity
on the part of lipids. Certain glycosphingolipids, which are
present in normal cells, are more abundant in tumor cells and
elicit an antibody response (Hakomori and Zhang, 1997). In
many cases, the precise chemical nature of the antigens remains
unclear and is dependent on cell type and experimental condi-
tions. Heteromeric glycolipid complexes, rather than an indi-
vidual glycolipid, modulate (auto)antibody responses (Rinaldi
et al., 2010), meaning that the antigenic determinant consists
of a combination of two (or more) glycans. One explanation for
this might be the different surface arrangement and presentation
of glycosphingolipids on tumor cells. Indeed, it is becoming
increasingly accepted that ‘‘local topography’’ influences
antigenicity and immunogenicity of glycosphingolipids. Another
explanation is that anti-lipid antibodies (of a limited range of iso-
types) against cardiolipin and other phospholipids might be
present at considerable frequencies but in hidden forms, for
example, as circulating immune complexes, and therefore
unable to engage normal tissues or cells (Alving, 2006). Lipids
from external sources are likely to produce immune responses.
Such lipids come from the diet or pathogens or are derivatives
of endogenous lipids, such as oxidized lipids and their adducts.
Indeed, there is increasing evidence for the presence of anti-lipid
antibodies, for example in individuals with HIV infections
and autoinflammatory conditions such as multiple sclerosis
(Kanter et al., 2006). Synthetic forms of lipid A have been used
to raise monoclonal antibodies that can be utilized in vivo to
target gram-negative bacteria (Syed et al., 1992). Antibodies
against lipid components of mycobacteria have been in
development for a number of years as a way of controlling
M. tuberculosis and M. leprae infections. These include anti-
bodies specific for lipoteichoic acid and lipoarabinomannan
(Hamasur et al., 2004).
Relatively little is known about the precise molecular require-
ments for successful generation of antibodies against lipids
either in terms of their presentation during immunization in vivo
or their selection in vitro. In an interesting example, liposomes
with very high content of cholesterol (71%) were used to
generate monoclonal antibodies that recognized membranes
with high cholesterol (as well as crystalline cholesterol in vitro)
but not liposomes with 40% cholesterol (Swartz et al., 1988).
Thus, there is reason to the hope that it will be possible to
generate new and specific lipid antibodies with improved
technologies for presentation and selection. Production of
pure, synthetic, and stable lipids is one prerequisite. A second,
more complicated issue is the selection of the lipid species
that acts as the antigen. Such antibodies, if successful, would
be entirely new tools for basic research in membrane trafficking
with applications in immunohistochemistry, cytochemistry, and
biochemistry. If proven highly specific, such antibodies could
be used for clinical applications, including for diagnostics or
potentially for therapeutic purposes.
Chemical Biology of Lipids
Small-molecule chemical probes (so-called activity-based or
affinity-based probes) have in recent years become increasingly
popular for the study of kinases, phosphatases, and hydrolytic
enzymes (hydrolases and proteases). To date relatively little
has been done to engineer lipid-based probes capable of
detecting or capturing lipid-interacting proteins. ‘‘Click chem-
istry’’ is a recently developed approach in which small molecules
can be joined selectively and has been used for selective
chemical remodeling of cell-surface glycoproteins (Mahal
et al., 1997). The technique builds on the assumption that
biosynthetic enzymes are promiscuous enough to allow incorpo-
ration of precursors that have a chemically reactive ‘‘molecular
handle’’ (a bio-orthogonal reporter) that subsequently can be
used to form a covalent bond with a fluorophore for visualization
or a solid resin for biochemical isolation. Such approaches
should in principle be applicable to lipids. Indeed, palmitoylation
(Martin and Cravatt, 2009; Yount et al., 2010) and myristoylation
(Martin et al., 2008) of proteins can be successfully studied using
such approaches. Alkyne-derivatized fatty acid incorporation
into cells, followed by solid-phase sequestration and release,
is a promising new method for unequivocally monitoring indi-
vidual glycerophospholipids (Milne et al., 2010). Bio-orthogonal
chemistry is not limited to the use of one reporter at a time. For
example, it can be combined with photoaffinity labeling. Such
strategies open new avenues for investigation of lipid-protein
interactions (Gubbens and de Kroon, 2010) or asymmetry across
a lipid bilayer. Fluorophosphonate derivates of phosphatidylcho-lines have been used to target phospholipases in protein
extracts with the proteins then identified via alkyne-azide-based
click chemistry (Tully and Cravatt, 2010).
Lipidomics across Biological Species
Many lipid metabolic pathways are conserved in function from
yeast toman. However, it is not trivial to search for lipid enzymes,
modulators of enzymes, or even lipid effectors based on protein
sequence information alone. Phosphatidylinositol transfer
proteins (PITPs), for example, share some functional redundancy
but almost no sequence similarity between yeast (Sec14p-like)
and metazoans. They also adopt very different structural folds.
Certain lipid classes differ substantially between biological
species. The sphingolipids in yeast, mammals, and insects
have very different head group decorations, hydroxylation
patterns, and lengths of fatty acids and long chain bases.
Thus, in addition to experimental methods (Guan et al., 2009;
Ejsing et al., 2009), new in silico approaches (Fahy et al., 2007;
Baker et al., 2008) are needed to tap the information stored in
existing databases, such as gene ontologies and protein-protein
interaction maps of model organisms.
Our appreciation of lipid heterogeneity, biosynthetic routes,
and process engineering has been substantially bolstered by
work coming out of the environmental and plant sciences. These
developments are supported by the belief that whatever can be
derived from fossil fuels can also be made from vegetable oils
and the fact that the cost differential between these two sources
of lipids has decreased over the past 20 years. Currently, 90% of
fossil oil is converted to fuel and 10% is used by the petrochem-
ical industry for production of plastics, detergents, etc. This
presents numerous opportunities for lipidomic research and
development, in addition to the obvious desire to generate
biofuels via food crops or other feedstock.
Take for example spermaceti oil (cetyl-palmitate, a wax),
which was harvested from the heads of sperm whales and
used in lubricants until whale hunting bans mandated the search
for alternative sources. It is indeed difficult to find a petroleum-
based replacement. Likewise, a wax derived from the seed of
the Jojoba plant is used in cosmetics and would also be a useful
industrial lubricant were it not for its current cost of production.
Several large-scale programs are currently addressing this
need. These efforts will likely tap into lipidomic technologies at
various levels. Ultra high-resolution mass spectrometry can be
used to provide detailed chemical information of petroleum
crude oils from different sources (Marshall and Rodgers, 2008).
This molecular information can then be used to correlate and
predict, using theoretical chemistry, their properties during the
refining process (chemical cracking). Mathematical modeling is
also applicable to enzymatic lipid metabolism (Miskovic and
Hatzimanikatis, 2010). Identification of lipid enzymes and their
cell biological and biochemical characterization will require
additional tools, some of which can be taken from the current
set that have proven successful in life sciences. New tools in
bioinformatics are needed to address plant-specific pathways.
For example, comparative deep sequencing of transcripts from
multiple plant tissues aided in the identification of an acyltrans-
ferase that produces an unusual triacylglycerol in which one of
the fatty acyls is an acetyl residue, rather than a fatty acid of
C16 or C18 (Durrett et al., 2010). This particular lipid hasCell 143, December 10, 2010 ª2010 Elsevier Inc. 893
desirable cold temperature properties, and thus this finding
might be readily translatable.Concluding Remarks
Methods based on mass spectrometry are now available for
qualitative and quantitative analysis of many major lipids in
complex samples (such as tissue and cell extracts) and from
several biological species (including yeast and mammals). The
near future promises technical improvements stemming from
cell isolation, sample fractionation and preparation, standardiza-
tion and cross-validation, and automation as well as wider
coverage of biochemical lipidomics from integration with
imaging, databases, and inclusion of additional biological
species. In parallel to these trends it can be anticipated that inter-
disciplinary programs will continue to integrate biochemical
lipidomics with chemical biology, proteomics, and genomics to
span the entire flow of information encoded in biological
systems. These efforts will provide us with a better under-
standing of natural variation found within lipids and will likely
lead to customized applications in life sciences, industrial
settings, and medicine.
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